Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
US9845318B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9845318-B2 |
| Application number | US-201514612890-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 3, 2015 |
| Priority date | Jun 6, 2011 |
| Publication date | Dec 19, 2017 |
| Grant date | Dec 19, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
2,5-Bis(benzoxazol-2′-yl)benzene-1,4-diol derivatives (Zinhbo derivatives) are used to detect zinc ions and have particular application in vivo and in vitro. Zinhbo derivatives upon excitation give a florescence response emission that can be used to determine the presence of zinc cation in solution. Zinhbo derivatives complexed with zinc cations upon excitation can produce a florescence response emission in the visible and near infrared range. Zinhbo derivatives complexed with zinc cations exhibit a large stoke shift between the excitation and emission wavelengths.
Opening claim text (preview).
The invention claimed is: 1. A method for detecting the presence of zinc ions in solution, the method comprising the steps of: contacting a solution with a Zinhbo derivative defined by the formula: where R 1 is an electron withdrawing group or a hydrogen atom; R 2 , R 3 , and R 4 are each individually selected from the group consisting of a hydrogen atom, an electron withdrawing group, and an electron donating group; and R 5 is a chelator group capable of forming a complex with a zinc cation; exciting the solution with an excitation wavelength; and measuring a fluorescence response emission in at least one of the visible or near infrared ranges; wherein the fluorescence response emission of the Zinhbo derivative corresponds to a Zinhbo derivative complexed with a zinc ion indicating the presence of zinc ions in the solution. 2. The method of claim 1 , where the Zinhbo derivative includes an R 1 , R 3 , and R 4 that are hydrogen atoms and an R 2 that is an electron donating group. 3. The method of claim 1 , where R 5 is a linear polyamine chelator or a cyclic polyamine chelator. 4. The method of claim 1 , where the solution includes a solvent selected from the group consisting of aqueous solvents, protic solvents, and organic solvents. 5. A method for detecting the presence of zinc ions, the method comprising the steps of: contacting living cells or a living organism with a Zinhbo derivative; exciting the living cells or the living organism with an excitation wavelength; and measuring a fluorescence response emission in at least one of the visible or near infrared range; wherein the fluorescence response emission of the Zinhbo derivative corresponds to a Zinhbo derivative complexed with a zinc ion indicating the presence of zinc ions in the living cells or living organism; where the Zinhbo derivative is defined by the formula: where R 1 is an electron withdrawing group or a hydrogen atom: R 2 , R 3 , and R 4 are each individually selected from the group consisting of a hydrogen atom, an electron withdrawing group, and an electron donating group; and R 5 is a chelator group capable of forming a complex with a zinc cation. 6. The method of claim 5 , where the Zinhbo derivative includes an R 1 , R 3 , and R 4 that are hydrogen atoms and an R 2 that is an electron donating group. 7. The method of claim 6 , where the electron donating group is an alkyl group. 8. The method of claim 5 , where living cells are contacted with a Zinhbo derivative and the living cells are cancer cells. 9. The method of claim 5 , where a living organism is contacted with a Zinhbo derivative. 10. The method of claim 5 , wherein said step of contacting living cells or a living organism includes delivering the Zinhbo derivative internally to an organism. 11. The method of claim 5 , where R 5 is a linear polyamine chelator or a cyclic polyamine chelator. 12. The method of claim 1 , where the solution includes zinc ions and the fluorescence response emission corresponds to a complexed Zinhbo derivative. 13. The method of claim 5 , where the living cells or the living organism includes free zinc ions and the fluorescence response emission corresponds to a complexed Zinhbo derivative.
linked by a carbon chain containing aromatic rings · CPC title
for measuring analytes not otherwise provided for, e.g. ions, cytochromes · CPC title
Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper {and including single- and multilayer analytical elements (immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72)} · CPC title
with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2 · CPC title
Zinc compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.